Partnership announcement VentureValuation/Biotechgate with ALLISNA

Venture Valuation/Biotechgate Partners with ALLIS-NA: Launch of Member Directory

Partnership announcement VentureValuation/Biotechgate with ALLISNA

Media Release

Venture Valuation/Biotechgate Partners with ALLIS-NA: Launch of Member Directory

Zurich, Switzerland and Paris, France, March 2023 – Venture Valuation/Biotechgate is proud to announce its partnership with the French regional health cluster Alliance Innovation Santé Nouvelle-Aquitaine (ALLIS-NA). The two organizations are collaborating to accelerate both the data integration in Biotechgate and economic development of the life science industry in the Nouvelle-Aquitaine region of France.

As part of this new cooperation, Venture Valuation created and launched a comprehensive membership directory for ALLIS-NA. The directory is freely accessible on the ALLIS-NA website and features over 140 members across ten different life science sectors, including Biotechnology, Pharma, Medical Technology, Digital Health, and more. The directory is designed to help companies easily search and connect with potential partners and collaborators.

In addition to the member directory, Venture Valuation will publish its annual report on the French life sciences industry later this year on the Biotechgate website, with significant cooperation and input from ALLIS-NA. This report promises to be a valuable resource for industry professionals, investors, and start-ups.

“We are excited to join forces with ALLIS-NA as dynamic and rapidly-growing health cluster. This partnership is another big step for us and underscores our commitment to expanding our global network of key industry associations in the life science sector,” – said Dr. Patrik Frei, CEO and Founder of Venture Valuation/Biotechgate. “The directory will boost the visibility of ALLIS-NA’s members and promote the strength of the life science network in Nouvelle-Aquitaine.”

“We are pleased to engage this collaboration with Biotech gate which will both promote the visibility of our members through the enhancement of their activities and enable us, as a hub for players in the health sector, to create economic and scientific bonds with our international counterparts for the benefit of our members in the Nouvelle-Aquitaine region (France).” – said Laurence Lachamp, general manager of ALLIS-NA.

The member directory is available at:

About Venture Valuation:

Venture Valuation was founded in 1999 based on profound research work by the founder and CEO, Dr. Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). The company has remained true to its mission: the independent assessment and valuation of companies, products and assets.

The focus lies on technology companies in fast growing markets and industries including pharmaceuticals, biotechnology (Biotech), medical technology (MedTech), nanotechnology, renewable energies (cleantech) and information technology (IT) / computer science / software. Clients include both, investors as well as finance-seeking companies themselves, and are domiciled on almost all continents.  Over the course of more than two decades, key strengths and expertise have been built in the life sciences industry.

About Biotechgate:

Biotechgate is a leading business development and licensing database for the entire life science industry, offering a wealth of information on over 65,000 life science company profiles. Thanks to its unique data sourcing process, the profiles include company descriptions, contact information, product pipeline information, financing rounds, and management details, making it an invaluable resource for big pharma, start-ups, investors, and other industry professionals. Biotechgate also features 25,000 licensing deals and a clinical trials database containing over 750,000 records from registries around the world.


The Alliance Innovation Santé Nouvelle-Aquitaine (ALLIS-NA) is the healthcare hub serving all actors in the health sector in the New Aquitaine region.  The primary objective of ALLIS-NA is to take part in the consolidation and economic growth of the sector throughout the region, by promoting innovation in the health sector and strengthening the competitiveness of regional companies and the attractiveness and development of the regional health ecosystem.

Today, ALLIS-NA brings together 140 members across the entire health value chain and the region, with 5 own facilities or partnerships.